Clinical Trials Directory

Trials / Completed

CompletedNCT06671652

Adaptation and Implementation of a Cherokee-based Participatory Research Project to Reduce CVD Risk

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
University of Missouri-Columbia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a two phase project. Phase I is an online convenience sample to collect health and preference data for the intervention phase, as well as a partnership with community to co-create an intervention; Phase II. Phase II is an intervention to improve community connection and historical knowledge within Cherokee communities within the Cherokee Nation reservation involving consultation with Cherokee cultural and historical experts.

Detailed description

1. Identify necessary program enhancements to maximize reach and acceptability of the intervention for primary prevention of CVD in Cherokee Nation adults. The new intervention will have a broad reach, and thus, potentially greater public health impact. By building on the well-established and popular intervention, RTR, the goal is to maximize the likelihood that this intervention will be culturally acceptable, logistically feasible, and financially sustainable. 2. Conduct a pilot study (n = 40) to demonstrate acceptability and feasibility of the adapted intervention and research methods. The expectation is that the intervention will be culturally acceptable to participants, and retention and data collection protocols will support feasibility of a larger randomized controlled trial.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDuyugoda igalenisodi (Starting again the right way)Participants in the intervention arm will receive training and resources to build community resources and programming

Timeline

Start date
2023-09-24
Primary completion
2024-06-01
Completion
2024-06-01
First posted
2024-11-04
Last updated
2026-03-13
Results posted
2026-03-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06671652. Inclusion in this directory is not an endorsement.